Laura Rodríguez-Díaz

Dr. Laura Rodríguez-Díaz

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ICInes Torras Caral
Ines Torras Caral
ICIsaac Cebrecos
Isaac Cebrecos
HCHelena Castillo
Helena Castillo
LRLaura Rodríguez-Díaz
Laura Rodríguez-Díaz
PZPablo Zaragoza-Ballester
Pablo Zaragoza-Ballester
EMEduard Mension
Eduard Mension
Background: Breast cancer (BC) recurrence, defined as the reappearance of cancer in the ipsilateral breast after primary treatment, poses significant challenges in clinical management. Despite advances in treatment, recurrence rates persist, ranging from 0.6 to 1.5% annually, reaching 10–15% at 20 years. This study aims to analyze the surgical and oncological characteristics of patients with BC recurrence. Methods: This retrospective study includes 56 patients diagnosed with recurrent BC between October 2018 and April 2022. Data were collected from a prospectively maintained surgical database. A descriptive analysis was performed on the initial BC, and the recurrence, including surgical complications, was classified using the Clavien–Dindo system. The success rates of selective sentinel lymph node (SLN) biopsies and aberrant drainages were assessed based on previous surgeries. Results: The cohort included 55 females and 1 male, with a median age of 65.3 years. The mean time to BC recurrence was 11.5 years. Among them, 26.8% underwent breast-conserving surgery, 41.1% had a mastectomy, 21.4% had a mastectomy with reconstruction, and 10.7% had an excision over a previous mastectomy. An SLN biopsy was performed in 78.6% of cases, with higher success rates in those without a previous axillary lymph node dissection (85.7% vs. 63.2%). Aberrant drainage was more frequent in patients with a previous ALND (44.4% vs. 20%). The median follow-up was 41.3 months, with 10.7% experiencing a second recurrence. Conclusions: Repeat breast-conserving surgery with re-irradiation for ipsilateral recurrence is feasible and does not significantly increase complications. SLN biopsy is valuable for restaging and tailoring adjuvant therapies, with ALND not being necessary if re-SLN biopsy shows no drainage. The management of aberrant drainage remains controversial.

24 September 2025 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Verified
Journal Article
Closed access
LRLaura Rodríguez-Díaz
Laura Rodríguez-Díaz
PZP. Zaragoza-Ballester
P. Zaragoza-Ballester
ITI. Torras
I. Torras
EME. Mensión
E. Mensión
ICI. Cebrecos
I. Cebrecos
SVS. Vidal-Sicart
S. Vidal-Sicart

19 September 2024 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
JSJuan P. Suarez
Juan P. Suarez
MDMaria L. Dominguez
Maria L. Dominguez
CVCarmen Vigil
Carmen Vigil
BFBelen Fernandez
Belen Fernandez
SNSara Naranjo
Sara Naranjo
FGFrancisco M. Gonzalez
Francisco M. Gonzalez

30 September 2024 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Verified
Journal Article
Closed access
LRLaura Rodríguez-Díaz
Laura Rodríguez-Díaz
EGE. García
E. García
CGC. de Guirior
C. de Guirior
RSR. Salvador
R. Salvador
JRJ. Ribera-Perianes
J. Ribera-Perianes
SVS. Vidal-Sicart
S. Vidal-Sicart